High-performance liquid chromatography (HPLC) confirms safe blood levels of slow-release bupivacaine nanoparticles.
|Articles|October 4, 2021
- October 2021
- Volume 17
- Issue 10
Vol 17 No 10 The Column October 2021 Europe & Asia PDF
Click the link above to open The Column October 2021 Europe & Asia issue, Volume 17, Number 10, in an interactive PDF format.
Advertisement
Articles in this issue
about 5 years ago
Three-Dimensional Printing in Ion Mobility and Mass Spectrometryabout 5 years ago
The LCGC Blog: The Analytical Arsenal for Point Source Attributionabout 5 years ago
Analyzing Glycerol in Biodiesel Using SPE and HPLC-RIabout 5 years ago
David R. Liu Announced as Recipient of Agilent Thought Leader Awardabout 5 years ago
Vol 17 No 10 The Column October 2021 North American PDFAdvertisement
Related to this article
Nano-liquid chromatography-high-resolution tandem mass spectrometry (nano-LC-HRMS/MS) reveals saliva protein shifts before and after multiple sclerosis therapy.
Max Besenhard explains how hybrid mechanistic and machine learning models can make HPLC method development quicker, more robust and ready for autonomous digital twins.
Ultra-high purity BIP® cylinders aim to give analytical laboratories cleaner baselines and lower detection limits
Polymer sorbent and dual microextraction boost gas chromatography with flame ionization detection (GC-FID) pesticide analysis.
Untargeted liquid chromatography–mass spectrometry (LC–MS) ties job stress in workers to plasma lipid changes.
Ultrahigh-pressure liquid chromatography–quadrupole time-of-flight mass spectrometry (UHPLC–QTOF MS) shows diet shapes honeybee metabolic responses to heat.
Advertisement
Advertisement
Trending on LCGC International
1
Industry Roundup: Air Products Advances Gas Chromatography Performance
2
Fast Low-Pressure Chiral GC for Pesticides in Wine
3
AI/ML Now: Hybrid Machine Learning for Experiment-Efficient HPLC
4
Nano-LC-MS/MS Tracks Saliva in Multiple Sclerosis
5